Structured evidence table for Astaxanthin Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Astaxanthin Blood Pressure Randomized Trial | From the natural medicine standpoint, it is also critical to emphasize that supplementation should not replace foundational interventions, such as proper nutrition, exercise, oral hygiene and risk factor control [,,], but rather complement them [,,]. | 1 | Malcangi Giuseppina (2026) | The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review |
| Astaxanthin Blood Pressure Randomized Trial | ASX exemplifies this concept: derived from algae, crustaceans or fish, it integrates into cellular membranes, modulates endogenous defense systems and exerts protective effects without the toxicity profile commonly associated with synthetic drugs [,]. | 1 | Malcangi Giuseppina (2026) | The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review |
| Astaxanthin Blood Pressure Randomized Trial | In preventive medicine, it may serve as a daily adjunct in populations at increased oxidative/inflammatory risk (e.g., ageing individuals, smokers, those with metabolic dysregulation) [,,,,]. | 1 | Malcangi Giuseppina (2026) | The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review |
| Astaxanthin Blood Pressure Randomized Trial | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Figure 1 Haematococcus pluvialis Carotenoids represent a family of naturally occurring pigments synthesized by plants, algae, bacteria and fungi [,,,,]. | 1 | Malcangi Giuseppina (2026) | The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review |
| Astaxanthin Blood Pressure Randomized Trial | It is imperative to develop a sustainable food system with a reduced environmental footprint [,,]. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Astaxanthin Blood Pressure Randomized Trial | We synthesize evidence on nutritional evaluation, application scenarios, and global regulatory differences, and analyze key bottlenecks. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Astaxanthin Blood Pressure Randomized Trial | These advances include improvements in cultivation systems such as closed photobioreactors and optimized open-pond systems that have enhanced biomass productivity and reduced contamination risks []. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Astaxanthin Blood Pressure Randomized Trial | 1 2 3 4 According to United Nations projections, the global population is expected to continue growing over the next 50–60 years, peaking at approximately 10.3 billion around the mid-2080s []. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
Source documents